• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝癌肝切除术前肝静脉压力梯度测量的价值。

Value of hepatic venous pressure gradient measurement before liver resection for hepatocellular carcinoma.

机构信息

Department of General Surgery, Medical University Vienna, Vienna, Austria.

出版信息

Br J Surg. 2011 Dec;98(12):1752-8. doi: 10.1002/bjs.7672. Epub 2011 Oct 19.

DOI:10.1002/bjs.7672
PMID:22009385
Abstract

BACKGROUND

Portal hypertension associated with liver cirrhosis increases the risk of postoperative complications after liver resection for hepatocellular carcinoma (HCC). This study assessed the role of preoperative hepatic venous pressure gradient (HVPG) assessment in identifying portal hypertension.

METHODS

All patients who underwent liver resection for HCC between January 2000 and December 2009 at the Department of General Surgery, Medical University Vienna, were analysed retrospectively. HVPG was assessed prospectively in a subset of patients before liver resection. The influence of this assessment on postoperative complications was investigated.

RESULTS

A total of 132 patients were enrolled, of whom 39 underwent HVPG measurement. Mean(s.d.) HVPG was 6·4(3·0) and 4·3(1·4) mmHg in patients with and without postoperative complications respectively (P = 0·028). Complication rates differed significantly at a cut-off HVPG value of 5 mmHg: 11 of 21 patients with a gradient of 1-5 mmHg developed complications versus 12 of 14 patients with a higher value (P = 0·045). HVPG exceeding 5 mmHg was associated with worse liver fibrosis (P = 0·004), higher rates of postoperative liver dysfunction (5 of 13 versus 1 of 18; P = 0·022) and ascites (7 of 14 versus 3 of 21; P = 0·022), and a longer hospital stay (median (range) 11 (7-26) versus 8 (4-20) days; P = 0·034). Overall postoperative morbidity did not differ between patients who had preoperative HVPG assessment and those who did not (P = 0·142).

CONCLUSION

Preoperative HVPG assessment predicted liver fibrosis and postoperative complications.

摘要

背景

与肝硬化相关的门静脉高压症增加了肝细胞癌(HCC)患者肝切除术后发生并发症的风险。本研究评估了术前肝静脉压力梯度(HVPG)评估在识别门静脉高压症中的作用。

方法

回顾性分析了 2000 年 1 月至 2009 年 12 月维也纳医科大学普通外科接受 HCC 肝切除术的所有患者。在肝切除术前对部分患者进行了前瞻性 HVPG 评估。研究调查了这种评估对术后并发症的影响。

结果

共纳入 132 例患者,其中 39 例行 HVPG 测量。术后并发症患者的 HVPG 平均值(标准差)为 6.4(3.0)mmHg,无并发症患者为 4.3(1.4)mmHg(P = 0.028)。HVPG 临界值为 5mmHg 时,并发症发生率差异显著:梯度为 1-5mmHg 的 21 例患者中有 11 例发生并发症,梯度>5mmHg 的 14 例患者中有 12 例发生并发症(P = 0.045)。HVPG 超过 5mmHg 与更严重的肝纤维化相关(P = 0.004)、术后肝功能障碍发生率更高(5/13 例与 1/18 例;P = 0.022)、腹水发生率更高(7/14 例与 3/21 例;P = 0.022)、住院时间更长(中位数(范围)为 11(7-26)天与 8(4-20)天;P = 0.034)。有术前 HVPG 评估的患者与无术前 HVPG 评估的患者术后总体发病率无差异(P = 0.142)。

结论

术前 HVPG 评估可预测肝纤维化和术后并发症。

相似文献

1
Value of hepatic venous pressure gradient measurement before liver resection for hepatocellular carcinoma.肝癌肝切除术前肝静脉压力梯度测量的价值。
Br J Surg. 2011 Dec;98(12):1752-8. doi: 10.1002/bjs.7672. Epub 2011 Oct 19.
2
Hepatic venous pressure gradient in the assessment of portal hypertension before liver resection in patients with cirrhosis.肝硬化患者肝切除术前评估门静脉高压的肝静脉压力梯度。
Br J Surg. 2012 Jun;99(6):855-63. doi: 10.1002/bjs.8753. Epub 2012 Apr 17.
3
[The adverse effect of indirectly diagnosed portal hypertension on the complications and prognosis after hepatic resection of hepatocellular carcinoma].[间接诊断的门静脉高压对肝细胞癌肝切除术后并发症及预后的不良影响]
Korean J Hepatol. 2006 Dec;12(4):553-61.
4
[Measurement of hepatic venous pressure gradient in liver cirrhosis: relationship with the status of cirrhosis, varices, and ascites in Korea].[韩国肝硬化患者肝静脉压力梯度的测量:与肝硬化状态、静脉曲张及腹水的关系]
Korean J Hepatol. 2008 Jun;14(2):150-8. doi: 10.3350/kjhep.2008.14.2.150.
5
Hepatic venous pressure gradient in the preoperative assessment of patients with resectable hepatocellular carcinoma.术前评估可切除性肝细胞癌患者的肝静脉压力梯度。
J Hepatol. 2016 Jan;64(1):79-86. doi: 10.1016/j.jhep.2015.08.025. Epub 2015 Aug 29.
6
Hepatic venous pressure gradient to assess fibrosis and its progression after liver transplantation for HCV cirrhosis.肝静脉压力梯度用于评估丙型肝炎病毒肝硬化肝移植后的纤维化及其进展。
Liver Transpl. 2007 Sep;13(9):1305-11. doi: 10.1002/lt.21227.
7
Measurement of portal venous pressure is useful for selecting the optimal type of resection in cirrhotic patients with hepatocellular carcinoma.门静脉压力测量对于选择肝细胞癌肝硬化患者的最佳切除类型很有用。
Hepatogastroenterology. 2005 Nov-Dec;52(66):1828-31.
8
Is portal hypertension a contraindication to hepatic resection?门脉高压是否是肝切除术的禁忌证?
Ann Surg. 2009 Dec;250(6):922-8. doi: 10.1097/SLA.0b013e3181b977a5.
9
Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.肝静脉压力梯度可预测代偿期肝硬化患者的临床失代偿情况。
Gastroenterology. 2007 Aug;133(2):481-8. doi: 10.1053/j.gastro.2007.05.024. Epub 2007 May 21.
10
Acoustic radiation force impulse imaging predicts postoperative ascites resulting from curative hepatic resection for hepatocellular carcinoma.声辐射力脉冲成像预测肝癌根治性切除术后腹水的发生。
Surgery. 2012 Jun;151(6):837-43. doi: 10.1016/j.surg.2011.12.035. Epub 2012 Mar 3.

引用本文的文献

1
Partial hepatectomy versus interventional treatment in patients with hepatitis B virus-related hepatocellular carcinoma and clinically significant portal hypertension: a randomized comparative clinical trial.部分肝切除术与介入治疗对乙型肝炎病毒相关肝细胞癌合并临床显著门静脉高压患者的随机对照临床试验。
Cancer Commun (Lond). 2024 Nov;44(11):1337-1349. doi: 10.1002/cac2.12614. Epub 2024 Sep 25.
2
History of liver surgery.肝脏手术史。
Clin Liver Dis (Hoboken). 2024 Jun 25;23(1):e0237. doi: 10.1097/CLD.0000000000000237. eCollection 2024 Jan-Jun.
3
Von Willebrand Factor Antigen Improves Risk Stratification for Patients with a Diagnosis of Resectable Hepatocellular Carcinoma.
血管性血友病因子抗原可改善可切除肝细胞癌患者的风险分层。
Ann Surg Oncol. 2024 Oct;31(10):6526-6536. doi: 10.1245/s10434-024-15618-w. Epub 2024 Jun 19.
4
The clinical value of the hepatic venous pressure gradient in patients undergoing hepatic resection for hepatocellular carcinoma with or without liver cirrhosis.肝静脉压力梯度在伴或不伴肝硬化的肝细胞癌患者肝切除术中的临床价值。
Open Med (Wars). 2024 Mar 8;19(1):20230851. doi: 10.1515/med-2023-0851. eCollection 2024.
5
Austrian consensus on the diagnosis and management of portal hypertension in advanced chronic liver disease (Billroth IV).奥地利共识:晚期慢性肝病中门静脉高压的诊断与管理(Billroth IV)。
Wien Klin Wochenschr. 2023 Sep;135(Suppl 3):493-523. doi: 10.1007/s00508-023-02229-w. Epub 2023 Jun 26.
6
Holistic management of hepatocellular carcinoma: The hepatologist's comprehensive playbook.肝细胞癌的整体化管理:肝病学家的综合诊疗手册。
Liver Int. 2022 Dec;42(12):2607-2619. doi: 10.1111/liv.15432. Epub 2022 Oct 11.
7
Impact of portal hypertension on short- and long-term outcomes after liver resection for intrahepatic cholangiocarcinoma: A propensity score matching analysis.门静脉高压症对肝内胆管细胞癌肝切除术后短期和长期结局的影响:倾向评分匹配分析。
Cancer Med. 2021 Oct;10(20):6985-6997. doi: 10.1002/cam4.4222. Epub 2021 Aug 18.
8
Combined APRI/ALBI score to predict mortality after hepatic resection.联合 APRI/ALBI 评分预测肝切除术后死亡率。
BJS Open. 2021 Jan 8;5(1). doi: 10.1093/bjsopen/zraa043.
9
Preoperative Inversed Albumin-to-Globulin Ratio Predicts Worse Oncologic Prognosis Following Curative Hepatectomy for Hepatocellular Carcinoma.术前白蛋白与球蛋白比值倒置预示肝细胞癌根治性肝切除术后肿瘤学预后更差。
Cancer Manag Res. 2020 Oct 12;12:9929-9939. doi: 10.2147/CMAR.S275307. eCollection 2020.
10
The value of indocyanine green clearance assessment to predict postoperative liver dysfunction in patients undergoing liver resection.吲哚菁绿清除率评估预测肝切除术后肝功能不全的价值。
Sci Rep. 2019 Jun 10;9(1):8421. doi: 10.1038/s41598-019-44815-x.